GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » YoY EBITDA Growth

NuGen Medical Devices (TSXV:NGMD) YoY EBITDA Growth : -11.11% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. NuGen Medical Devices's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -11.11%.

NuGen Medical Devices's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.01.

NuGen Medical Devices YoY EBITDA Growth Historical Data

The historical data trend for NuGen Medical Devices's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices YoY EBITDA Growth Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -146.67 41.89 -2.33

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 57.58 - 16.67 -11.11

NuGen Medical Devices YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

NuGen Medical Devices's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.044--0.043)/ | -0.043 |
=-2.33 %

NuGen Medical Devices's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-0.01--0.009)/ | -0.009 |
=-11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

NuGen Medical Devices (TSXV:NGMD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » YoY EBITDA Growth
Comparable Companies
XCNQ:BLO TSXV:VPT TSXV:ASG TSXV:SGMD TSX:TMD TSXV:MDX TSXV:THRM XCNQ:PMED TSXV:FREQ TSXV:TLT ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
NGMDF:USA 79O:Germany
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
Website
https://www.nugenmd.com
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Asia, Europe and others.
Executives
Richard Buzbuzian Director, Senior Officer

NuGen Medical Devices (TSXV:NGMD) Headlines

No Headlines